Popularity #2,132Earnings today
Rezolute (RZLT)
Developing ersodetug for hypoglycemia caused by congenital and tumor hyperinsulinism.
$4.07
vs last close+0.16 (+4.12%)
Something off on this page? Send us feedback.
Next report
Sep 22, 26
estimated · today
EPS estimate
−$0.15
Revenue estimate
—
Fiscal quarter
Q4 FY26
EPSReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported−$0.22−$0.22−$0.27−$0.26−$0.18−$0.22−$0.16Pending
Estimate−$0.35−$0.33−$0.22−$0.23−$0.27−$0.16−$0.14−$0.15
Surprise+37.1%+33.3%−22.7%−13.0%+33.3%−37.5%−12.3%—
RevenueReportedEstimate
Nov '24Feb '25May '25Sep '25Nov '25Feb '26May '26Sep '26
Reported———————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Jun 2027 | −$0.14 | — | — |
| Mar 2027 | −$0.15 | — | — |
| Dec 2026 | −$0.13 | — | — |
| Nov 2026 | −$0.15 | — | — |
| Sep 2026 | −$0.15 | — | — |
| May 2026 | −$0.14 | −$0.16 | −12.3% |
| Feb 2026 | −$0.16 | −$0.22 | −37.5% |
| Nov 2025 | −$0.27 | −$0.18 | +33.3% |
| Sep 2025 | −$0.23 | −$0.26 | −13.0% |
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Sep 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Sep 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Sep 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Sep 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Oct 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Sep 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Dec 2018 | |||
| Dec 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Jun 2027 | −$0.14 | — | — | $1.3M | — | — | — |
| Mar 2027 | −$0.15 | — | — | $1.3M | — | — | — |
| Dec 2026 | −$0.13 | — | — | $1.2M | — | — | — |
| Nov 5, 2026 | −$0.15 | — | — | $1.1M | — | — | — |
| Sep 22, 2026 | −$0.15 | — | — | $0 | — | — | — |
| May 12, 2026 | −$0.14 | −$0.16 | −12.3% | — | — | — | +0.9% |
| Feb 12, 2026 | −$0.16 | −$0.22 | −37.5% | — | — | — | +5.8% |
| Nov 6, 2025 | −$0.27 | −$0.18 | +33.3% | — | — | — | +2.7% |
| Sep 17, 2025 | −$0.23 | −$0.26 | −13.0% | — | — | — | −0.1% |
| May 13, 2025 | |||||||
| Feb 12, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Sep 19, 2024 | |||||||
| May 15, 2024 | |||||||
| Feb 13, 2024 | |||||||
| Nov 13, 2023 | |||||||
| Sep 14, 2023 | |||||||
| May 11, 2023 | |||||||
| Feb 10, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Sep 15, 2022 | |||||||
| May 12, 2022 | |||||||
| Feb 9, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Sep 15, 2021 | |||||||
| May 17, 2021 | |||||||
| Feb 10, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Oct 13, 2020 | |||||||
| May 14, 2020 | |||||||
| Feb 12, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Sep 10, 2019 | |||||||
| May 10, 2019 | |||||||
| Feb 14, 2019 | |||||||
| Dec 14, 2018 | |||||||
| Dec 31, 2018 | |||||||
| May 15, 2018 | |||||||
| Feb 14, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Sep 22, 2017 | |||||||
| May 15, 2017 | |||||||
| Feb 2, 2017 | |||||||
| Nov 14, 2016 | |||||||
| Sep 28, 2016 | |||||||
| May 16, 2016 | |||||||
| Feb 16, 2016 | |||||||
| Nov 16, 2015 | |||||||
| Sep 30, 2015 |